|
Volumn 12, Issue 7, 2001, Pages 569-574
|
Thymidylate synthase as a molecular target for drug discovery using the National Cancer Institute's Anticancer Drug Screen
|
Author keywords
COMPARE analysis; NCI Anticancer Drug Screen; Thymidylate synthase; UNIDRUG
|
Indexed keywords
ANTINEOPLASTIC AGENT;
FLUOROPYRIMIDINE DERIVATIVE;
FOLIC ACID ANTAGONIST;
THYMIDYLATE SYNTHASE;
ALGORITHM;
ARTICLE;
CANCER CELL CULTURE;
CANCER CHEMOTHERAPY;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG MECHANISM;
DRUG SCREENING;
GENE OVEREXPRESSION;
GENE TARGETING;
HUMAN;
HUMAN CELL;
PRIORITY JOURNAL;
WESTERN BLOTTING;
ANTINEOPLASTIC AGENTS;
BLOTTING, WESTERN;
CELL DIVISION;
DRUG EVALUATION, PRECLINICAL;
DRUG SCREENING ASSAYS, ANTITUMOR;
ENZYME INHIBITORS;
FEMALE;
HUMANS;
MALE;
NATIONAL INSTITUTES OF HEALTH (U.S.);
NEOPLASMS;
THYMIDYLATE SYNTHASE;
TUMOR CELLS, CULTURED;
UNITED STATES;
|
EID: 0034887089
PISSN: 09594973
EISSN: None
Source Type: Journal
DOI: 10.1097/00001813-200108000-00002 Document Type: Article |
Times cited : (5)
|
References (9)
|